ActivaTek

Name

ActivaTek

Legal name

ActivaTek

Website

https://activatekinc.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Iontophoresis Drug Delivery Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLACAFAL

Connected Therapeutics & Smart Drug Delivery Monitoring

Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

SECONDARYHLACAPAH

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHLAHAIAM

Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)

Keywords

• Iontophoresis drug delivery
• Transdermal medical devices
• Rehabilitation pain management
• Physical therapy equipment
• Medical electrode systems

Headquarters

HQ city

Gilroy

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Hardware Sales: Sale of iontophoresis controllers and systems including ActivaDose II controllers and related equipment. One-time hardware purchases with one-year warranty.
2. Consumable/Disposable Products: Sale of single-use electrode kits (Trivarion), iontophoresis patches (ActivaPatch), and related consumables. Trivarion sold in boxes of 12 treatment kits, each containing active delivery electrode, return electrode, and alcohol prep pad.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

ActivaTek develops and markets iontophoresis-based transdermal drug delivery medical devices, including the Trivarion® buffered electrode delivery kit, the ActivaDose® II dual-channel precision dose controller, and the ActivaPatch® wireless self-contained microprocessor-controlled treatment patch. Products are sold through North Coast Medical's distribution network to healthcare professionals for in-clinic pain management and rehabilitation use, with secondary availability for patient home use.

Product overview

ActivaTek offers a portfolio of iontophoresis-based transdermal drug delivery products. The core offering consists of three integrated products: Trivarion® (a buffered delivery electrode system using Carbon-Ag/AgCl technology for precise ion delivery), ActivaPatch® (a self-contained wireless iontophoresis patch with onboard microprocessor for real-time monitoring), and ActivaDose® II (a dual-channel dose controller for in-clinic precision dosing). The products work together as a complete drug delivery ecosystem, with Trivarion® electrodes and ActivaPatch® patches used with the ActivaDose® II controller for clinical treatments. The company also operates ActivaDerm, a sister company targeting dermatological and cosmetic applications.

Differentiator

Problem solved

Functional benefit

Brands

• Trivarion®: Buffered iontophoresis delivery technology with Carbon-Ag/AgCl technology for precise ion delivery up to 80 mA*min with balanced pH.
• ActivaDose®
• ActivaPatch®
• ActivaDerm, Inc.

Products and services

• Trivarion® Iontophoresis Delivery Kit Single-use buffered iontophoresis delivery electrode kit using Carbon-Ag/AgCl technology to deliver charged drug molecules through the skin with precise pH balance up to 80 mA*min. Sold in boxes of 12 kits, each containing an active delivery electrode, return electrode, and alcohol prep pad; compatible with ActivaDose® II Controller. Designed for healthcare professionals and patients treating uneven sites like elbows, shoulders, and knees.
• ActivaDose® II Dose Controller Dual-channel in-clinic dose controller for iontophoresis treatments, featuring precise dosing (0-80 mA-min range, 0.1 mA-min increments), up to 80 volts output, automatic current ramp-up/down, high-contrast display, dual controls with optional push-knob or turn capabilities, and visual/audible alerts for resistance, dose/current limits, and electrode reject. Includes Single Channel Controller, lead wires, batteries, and an instruction manual with a one-year warranty.
• ActivaPatch® Wireless Iontophoresis Patch Self-powered, extended-wear single-use iontophoresis patch with an onboard intelligent microprocessor that detects skin resistance, adjusts current automatically, memorizes treatment times, and provides real-time LED feedback for accurate and consistent drug delivery without external devices or complex setups. Sourced for purchase through ncmedical.com.

Quantifiable outcome

• Over 80% of specified dosage delivered with minimal variation, outperforming other devices that showed significant under-delivery of medication.
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• North Coast Medical, Inc.coreChannel Partner/ Reseller/ DistributorNorth Coast Medical acquired ActivaTek and serves as the primary distribution partner. ActivaTek is operated as a brand under North Coast Medical, leveraging their extensive resources and distribution network to reach healthcare providers and patients globally. Products are sold through ncmedical.com with full customer support.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Vyteris / Galderma Latticed System: Galderma (formerly through Vyteris) markets active transdermal / iontophoretic drug-delivery technologies for dermatology applications, overlapping ActivaTek's transdermal and dermatology focus, including the ActivaDerm sister brand.
• Mettler Electronics: Producer of clinical iontophoresis, ultrasound, and electrotherapy devices sold to physical therapists and sports medicine clinics, competing for the same clinician purchasing decisions as ActivaTek.
• Wescor / ELITechGroup (Macroduct Sweat Testing): ELITechGroup's Wescor subsidiary markets iontophoretic drug-delivery systems (e.g., pilocarpine iontophoresis for sweat testing), using the same electrotransport technology platform for diagnostic and clinical applications.
• Life-Tech International: Long-standing maker of clinical iontophoresis devices and electrodes comparable to ActivaDose and Trivarion, serving the same physical therapy and rehabilitation customer base.
• Rich-Mar (InTENSity/Richmar): Manufacturer of iontophoresis and combination ultrasound/electrotherapy devices used in physical therapy clinics, offering overlapping clinical product lines to ActivaTek's installed base.

Broad incumbents

• Empi (DJO/Enovis): Empi, part of DJO/Enovis, has long sold iontophoresis devices (e.g., ActivaPatch-compatible electrodes) and competes directly with ActivaTek in physical therapy and rehabilitation channels, with a much broader orthopedic and pain management portfolio.
• Chattem / Sanofi Consumer Healthcare (Iontocaine): Marketer of Iontocaine, a lidocaine/epinephrine iontophoresis system used for dermal anesthesia, making it a direct competing iontophoretic drug-delivery product aimed at clinicians seeking needle-free local anesthesia.

Others

• North Coast Medical (parent): Acquirer of ActivaTek and primary distribution partner; not a product competitor in iontophoresis but operates the channel through which ActivaTek devices and consumables reach clinicians and patients.

Emerging players

• CureTape / Wincoat (TENS and iontophoresis): Smaller competitor offering iontophoresis and related electrotherapy consumables for sports medicine and physiotherapy, competing on price-sensitive clinic channels with ActivaPatch alternatives.
• Pantex Laboratories / Acrux (Emsam, transdermal): Acrux develops topical/transdermal drug-delivery platforms (e.g., Axiron) that overlap with ActivaTek's mission of needle-free transdermal delivery, though using a non-iontophoretic chemical permeation approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ActivaTek